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Abstract
Advanced glycation end products (AGEs) irreversibly
cross-link proteins with sugars and accumulate at a high-
er age and in diabetes, processes which can interfere
with the integration of implants into the tissue. Glyoxal is
a highly reactive glycating agent involved in the forma-
tion of AGEs and is known to induce apoptosis, as
revealed by the upregulation of caspase-3 and fractin
(caspase-3 being a key enzyme activated during the late
stage of apoptosis and fractin being a caspase-cleaved
actin fragment). In this study, we investigated the in-
fluence of collagen type I coating on the cytotoxic effect
of glyoxal on rat calvarial osteoblastic cells and on
human osteosarcoma cells (Saos-2) grown on titanium
alloy, Ti6Al4V. Activation of caspase-3 and fractin was
measured by counting immunohistochemically stained
cells and by flow cytometry with propidium iodide (de-
tection of the apoptosis indicating a sub-G1 peak). Our
results showed an increased number of apoptotic osteo-
blasts after incubation with glyoxal on Ti6Al4V discs.
However, the number of apoptotic cells on collagen-
coated titanium was significantly smaller than on un-
coated titanium after the same treatment. The present
findings demonstrate that osteoblasts treated with
glyoxal undergo apoptosis, whereas collagen type I coat-
ing of titanium alloys (used for implants) has an anti-
apoptotic function.
Copyright © 2004 S. Karger AG, Basel
Introduction
The ability of an implant to integrate into the bone is a
prerequisite for clinical success [Cooper, 1998; Lohmann
et al., 1999]. Implant surface coating, roughness and
chemistry influence the adhesion, proliferation, and dif-
ferentiation of osteoblastic cells on implants [Martin et
al., 1995; Degasne et al., 1999].
Collagen type I is one of the major extracellular matrix
proteins that can be found in fibrous tissue and bone. Pre-
coating titanium alloy (Ti6Al4V) with collagen type I pro-
motes adhesion and spreading of rat calvarial osteoblasts
and leads to specific cell-implant interactions, which was
Abbrevations used in this paper
AFM atomic force microscope
AGEs Advanced glycation end products
BL uncoated (blank)
CML Â-N-(carboxymethyl)lysine
FC fibrillar collagen
FITC fluorescein isothiocyanate
GO glyoxal
PBS phosphate-buffered saline
SEM scanning electron microscope 
Ti6Al4V titanium alloy
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shown by our groups [Geissler et al., 2000; Röhlecke et al.,
2001]. We have also shown that collagen contributes to
cell spreading and a more rapid formation of focal adhe-
sions [Röhlecke et al., 2001; Becker et al., 2002]. In gener-
al, the adhesion of cells to the extracellular matrix and
cell-cell interactions have been observed to suppress
apoptosis in many cell types, including osteoblasts [Boud-
teau et al., 1995; Krestow et al., 1999; Hunter et al.,
2001].
According to these findings we hypothesized that colla-
gen coating of titanium alloys is able to reduce apoptosis
of osteoblasts due to changes in interactions between cells
and extracellular matrix. To address this question, we
exposed cultivated osteoblast-like cells with glyoxal, a
known apoptosis-inducing agent which is involved in the
formation of advanced glycation end products (AGEs)
[Thornalley and Stern, 1984; Thornalley, 1999].
AGEs are heterogeneous stable end-stage substances
formed by the nonenzymatic glycation of proteins, nu-
cleotides and phospholipids. The accumulation of AGEs
in vivo has been linked to normal aging and occurs at an
accelerated rate in the development of diabetes complica-
tions and neurodegenerative diseases [Lyons et al., 1991;
McCance et al., 1993]. Diabetes in both humans and rats
is accompanied by impaired bone formation [Bouillon et
al., 1995; Krakauer et al., 1995; Katayama et al., 1996;
Takeshita et al., 1997].
Early glycation involves the reaction of glucose with
N-terminal and lysyl side chain amino groups to form
Schiff’s base and fructosamine adducts. Glucose (50 mM)
degrades slowly at pH 7.4 and 37°C to form glyoxal (59.5
B 3.7 ÌM), methylglyoxal (2.77 B 1.22 ÌM) and 3-de-
oxyglucosone (7.46 B 1.48 ÌM). The concentrations of
these ·-oxoaldehydes increased rapidly in an in vitro
assay over the initial 2–5 days [Thornalley et al., 1999]. In
cells, transmembrane surface receptors for AGE include
galectin-3, and the macrophage scavenger receptors p60
and p90 [Thornalley, 1998].
There is evidence that Â-N-(carboxymethyl)lysine
(CML) modifications of proteins are the predominant
AGEs that accumulate in vivo [Berg et al., 1998; Kislinger
et al., 1999; Wagner et al., 2001]. CML (which we use in
this paper as immunostaining marker for ‘aged’ proteins)
is a chemically defined AGE formed on proteins by glyca-
tion and lipid peroxidation as well as by auto-oxidation of
lipids, amino acids and carbohydrates [Miyata and Kur-
rokawa, 1999]. In a previous study we could show that
CML, bax and active caspase-3 as well as apoptotic events
increased after incubation with glyoxal [Reber et al.,
2003].
In the present study, we examined the cytotoxic effect
of glyoxal on osteoblasts in general, and then tested if col-
lagen coating of titanium alloy reduced the cytotoxic
effect of glyoxal.
Apoptotic cells were detected by flow cytometry (pro-
pidium iodide showing the apoptosis indicating a sub-G1
peak) and immunohistochemically using antibodies
against caspase-3, a key enzyme during apoptosis, and
against fractin, an actin fragment generated by caspase-3
cleavage [Rossiter et al., 2000; Reber et al., 2002] and a
valuable marker of apoptosis in various tissues [Pulera et
al., 1998; Rossiter et al., 2000; Elibol et al., 2001].
Actin cleavage by caspase-3, in particular, results in the
breakdown of the cytoskeleton membrane blebbing, and
the release of DNase I, which enters the nucleus and
induces DNA fragmentation [Kayalar et al., 1996]. The
anti-fractin antibody was raised against the C-terminus
32-kD actin fragment, which is formed by the caspase-
3-mediated cleavage at 244 aspartate residue [Yang et al.,
1998]. It is specific for the 32-kD fragment, but does not
recognize the intact actin.
For clinical relevance we found it important to include
both animal primary cultures (rat calvarial osteoblasts)
and human cells (osteosarcoma cell line, Saos-2). Cell
lines behave sometimes slightly differently compared to
fresh primary cultures. On the other hand, it is important
to also include human cells which allow a better compari-
son with the in vivo situation in patients.
Materials and Methods
Preparation of Modified Surfaces
As substrates for the cell experiments, the following surface states
were used: Ti6Al4V coated with collagen type I (fibrillar collagen,
FC) and Ti6Al4V without coating [uncoated (blank), BL] prepared in
collaboration with Dr. S. Bierbaum at the Department of Biomate-
rials at the TU Dresden.
Experiments were performed on glass coverslips with a diameter
of 16 mm (2 cm2) magnetron-sputtered with 50 nm Ti6Al4V alloy.
Scanning electron microscope (SEM) and atomic force microscope
(AFM) images of these metallic layers showed a cluster structure in
the nanometer region. The sputtered Ti6Al4V substrates were
cleaned with 1% Triton X-100, acetone and 96% ethanol, rinsed with
distilled water, and air dried. The Ti6Al4V discs were coated with FC
with an improved adsorption method [Rössler et al., 1999, 2000].
For collagen coatings, collagen fibrils were prepared by mixing in
an equal amount of a fibrillogenesis buffer with 1 mg/ml solution of
acid-soluble calf skin collagen type I (Fluka, Deisenhofen, Germany),
which had been dissolved overnight in 10 mM acetic acid and then
centrifuged 10,000 g for 30 min at 4°C. Following overnight incuba-
tion at 37°C, the resulting gel was homogenized, fibrils were col-
lected by centrifugation at 5,000 g for 15 min, washed with fibrillo-
genesis buffer diluted to a working concentration, and centrifuged
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Table 1. List of antibodies used for immunohistochemistry
Antibody Specificity Species Dilution Source
Caspase-3 active caspase-3 rabbit, polyclonal 1:20 PharMingen
Heidelberg, Germany
CML CML rabbit, polyclonal 1:1,000 Dr. Schleicher
University of Tübingen, Germany
Fractin fractin rabbit, polyclonal 1:1,000 PharMingen
Heidelberg, Germany
again. The pellet was resuspended in the same buffer to a concentra-
tion of F1 mg/ml collagen. The titanium-coated discs were incu-
bated in suspension with collagen solution at 25°C for 15 min,
washed with distilled water, and air dried. For cell culture experi-
ments, coated (FC) and uncoated (BL) discs were sterilized with
100% ethylene oxide at 42 °C for 12 h. Morphological investigations
were carried out with a digital SEM (DSM 982 Gemini; Carl Zeiss,
Oberkochen, Germany) and an AFM (NanoScope IIIa; Digital
Instruments, Santa Barbara, Calif., USA). There was no measurable
detachment of collagen after exposure of the coated titanium alloy to
the cell culture medium for several weeks [Lowenberg et al., 1988;
Rössler et al., 1999; Geissler et al., 2000; Rössler et al., 2000]. Fur-
thermore, members of our groups demonstrated on collagen type I-
coated titanium alloys in rat tibiae that no abrasion of collagen type I
from the implants occurred during 6–8 weeks of implantation time
[Rammelt et al., 2002a, b].
Cell Cultures
The human osteoblast-like cell line, Saos-2 cells, obtained from
American Tissue Culture Collection (Manassas, Va., USA), and a
p53-negative cell line, were grown at 37°C in 5% CO2 in McCoy’s 5A
medium supplemented with 15% fetal calf serum and 10 mg/ml gen-
tamycin.
Primary osteoblasts were obtained from fetal rat calvarial sam-
ples by collagenase digestion. The bone samples were dissected to
approximately 1-mm3 fragments after removal of the periosteum.
They were washed first with Tyrode’s solution and then with Ham’s
F12 medium. They were then digested in 4 ml of collagenase-trypsin
solution [137 mg of collagenase type I (Biochrom, Berlin, Germany)
and 50 mg of trypsin type III (Sigma, Deisenhofen, Germany) in
10 ml of deionized H2O containing 8 g of NaCl, 0.2 g of KCl and
0.05 g of NaH2PO4 WH2O per 100 ml of deionized H2O] at room tem-
perature. Cells from the first 45-min digestion were discarded. The
second and third 30-min digests (in 4 ml of fresh collagenase-trypsin
solution) were centrifuged for 2 min at 600 g. The cell pellets were
resuspended in 4 ml Ham’s F12 medium containing 20% fetal calf
serum. After 10 min of centrifugation at 500 g, the cells were plated
in full medium, i.e. 12 ml of Ham’s F12 medium containing 12%
fetal calf serum, 2.3 mM Mg2+, 100 IU/ml penicillin and 100 Ìg/ml
streptomycin sulfate. The medium was changed every 3 days. The
osteoblast phenotype was characterized by determining alkaline
phosphatase activity, collagen type I synthesis and formation of cal-
cium phosphate deposits. The cells for each experiments were used
for 5th and 6th passages. The cultures were maintained at 37°C in
humidified air and 5% CO2. Cell viability was assessed by trypan
blue dye exclusion.
Application of Cells to Implants and Exposure to Glyoxal
The titanium-coated discs were placed into 12-well Falcon cul-
ture plates (Becton Dickinson, Heidelberg, Germany). Primary os-
teoblasts and Saos-2 cells were detached using 0.05% trypsin-0.02%
EDTA in phosphate-buffered saline (PBS) and plated on the discs to
a single-cell density of 10,000 cells/cm2. Cells were allowed to settle
for 2 h in the incubator at 37°C in PBS, which was then replaced
with 2 ml complete medium and nonadherent cells were gently
removed. After 24 h in culture, primary osteoblasts were treated for
24 or 72 h with 0 ÌM (control), 100, 200, 400 and 600 ÌM glyoxal
(40% aqueous solution; Sigma-Aldrich) while Saos-2 cells were
treated for the same time with 0 (control), 50, 100, 200 and 300 ÌM
glyoxal. For the sub-G1 test (see Flow Cytometry below), the Saos-2
cells were treated for 24 or 72 h with 200, 300 and 400 ÌM glyoxal.
Cell viability prior to incubation with glyoxal was assessed by trypan
blue dye exclusion.
Immunocytochemistry and Quantitative Microscopy
For immunocytochemistry, the medium was removed and cells
were washed 3 times with PBS. Cells were then fixed with 4% buff-
ered paraformaldehyde for 5 min at room temperature. After wash-
ing with PBS, cells were permeabilized with 0.5% Triton X-100 in
PBS for 6 min and then incubated with 1% bovine serum albumin for
10 min. Cells were incubated overnight at 4°C with polyclonal, anti-
sera against caspase-3 (active caspase-3, rabbit, polyclonal; 1:20;
PharMingen, Heidelberg, Germany), fractin (rabbit, polyclonal,
1:1,000; Dr. Schleicher, University of Tübingen) or CML (rabbit,
polyclonal, 1:1,000; PharMingen) (table 1). After washing, the cells
were exposed to a fluorescein isothiocyanate (FITC)-conjugated goat
anti-rabbit secondary antibody (1:100; Dianova, Hamburg, Germa-
ny) for 1 h at room temperature. After rinsing 3 times with PBS,
bisbenzimid (Hoechst; 1:1,000) was added for 15 min. Cellular fluo-
rescence was evaluated with a conventional fluorescence microscope
(Leica, Bensheim, Germany). The FITC wavelengths for excitation
average at 490 nm and emission at 525 nm, bisbenzimid wavelengths
for excitation at 365 nm and emission at 480 nm. Pictures were cap-
tured with a Nikon Coolpix 995.
After staining with bisbenzimid, apoptotic cells exhibited in blue
condensed nuclei and fragmented chromatin. Quantification of
apoptotic cells in each culture condition was performed by counting
the number of cells with fragmented chromatin within six random
fields of sight (0.5985 mm2). Experiments were independently re-
peated 9 times. Data are presented as mean B SD. Differences
between Ti6Al4V collagen type I (FC) and Ti6Al4V uncoated (BL)
were evaluated with the paired Student t test. The Student t test is a
parametric test for the comparison of the average values of two inde-
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Fig. 1. Percentage of apoptotic cells (with
fragmented chromatin, staining with bisben-
zimid) of calvarial (A, B) and Saos-2 (C, D)
cells after treatment for 24 h (A, C) and 72 h
(B, D) with different glyoxal (GO) concentra-
tions. Cells were cultured on BL and FC-
coated titanium alloy. The histogram shows
the influence of FC on the antiapoptotic
behavior of calvarial cells and Saos-2 cells
after incubation of cells with various GO
concentrations. Representative data from
nine experiments are shown. * p ! 0.05;
** p ! 0.01 FC vs. BL.
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pendent samples out of the normally distributed universe test statis-
tic t. Calculations were performed using the statistical package SPSS
11.0 (SPSS, Professional Statistics, Chicago, Ill., USA) and signifi-
cance was accepted at * p ! 0.05; ** p ! 0.01 FC vs. BL.
Flow Cytometry
Apoptosis of cells plated on Ti6Al4V-coated discs with (FC) or
without (BL) collagen type I was assessed by flow cytometry (sub-G1)
as described [Nicoletti et al., 1991] after treatment with 300 ÌM of
glyoxal. Control cells were grown on the same plates, but were not
exposed to glyoxal. Briefly, cells were fixed by adding 70% ethanol.
Fragmented DNA was extracted with a buffer containing 0.192 M
Na2HPO4 and 4 mM citric acid, pH 7.8. Staining was performed
with 20 Ìg/ml propidium iodide and 200 Ìg/ml RNase A (Becton
Dickinson) in PBS, pH 7.4 for 30 min at room temperature. Cells
were analyzed using a FACSCalibur (Becton Dickinson) [Darzynkie-
wicz et al., 1992]. Apoptotic cells were revealed by a hypodiploid
DNA peak with a weaker fluorescence than the normal G1 peak
[Gong et al., 1994].
Results
Glyoxal-Induced Apoptosis in Rat Calvarial Cells and
Saos-2 Osteoblastic Cells
Figure 1 shows the percentage of calvarial (fig. 1A, B)
and Saos-2 (fig. 1C, D) apoptotic cells after treatment
with different glyoxal concentrations for 24 h (fig. 1A, C)
and 72 h (fig. 1B, D) by counting the bisbenzimid-stained
fragmented and condensed nuclei.
In calvarial cells, glyoxal for 24 h induced apoptosis in
a dose-dependent manner: 100, 200, 400 and 600 ÌM
glyoxal induced apoptosis in 55, 67, 70 and 85% of the
cells, respectively (fig. 1A). After 72 h incubation with
glyoxal at the indicated concentrations, the apoptotic cell
rate was further increased to 70, 85, 90 and 92% (fig. 1B).
A similar dose- and time-response to glyoxal was
observed in Saos-2 cells (fig. 1C, D). Treatment over a
period of 24 h with 50, 100, 200 and 300 ÌM glyoxal
induced 5, 12, 32 and 50% apoptosis of Saos-2 cells,
respectively (fig. 1C). After 72 h glyoxal treatment, the
corresponding apoptosis rates increased to 9, 15, 64 and
85% (fig. 1D). Higher concentrations or longer incubation
with glyoxal induced 100% cell death. In general, Saos-2
cells responded to lower glyoxal concentrations than cal-
varial cells.
Furthermore, fewer calvarial cells and even fewer
Saos-2 cells underwent apoptosis on collagen-coated titan-
ium discs (FC) than on uncoated titanium discs (BL)
(compare fig. 1A and B with fig. 1C and D). Thus, the col-
lagen coating had a protective effect, with a decreased
apoptotic rate in Saos-2 cells (10–30% less) compared to
uncoated surfaces. In addition, these results revealed that
even a small concentration of glyoxal is sufficient to
induce apoptosis of human cells.
The sub-G1 tests by flow cytometry corroborated our
microscopical observations. Higher concentrations and
longer incubation with glyoxal resulted in increased apo-
ptotic rates (fig. 2). Moreover, the number of apoptotic
cells on collagen-coated titanium was much smaller than
on uncoated titanium. For instance, after treatment with
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300 ÌM glyoxal for 24 h, propidium iodide fluorescence
was much higher in Saos-2 cells grown on uncoated than
on collagen-coated discs. Data are shown in figure 2.
Glyoxal-Induced Apoptosis: Upregulation of
Caspase-3, Fractin and CML
Double immunofluorescence (bisbenzimid and cas-
pase-3 or fractin) demonstrated that treatment with glyox-
al caused the activation of caspase-3 (fig. 3) and fractin
(fig. 4) in calvarial and Saos-2 cells, as expected in apo-
ptotic cells.
In the absence of glyoxal, cell cultures grown on colla-
gen-coated or uncoated titanium discs included fewer
apoptotic cells, as revealed by staining for activated cas-
pase-3 and fractin (data not shown). Double immuno-
fluoresence showed that fractin-positive cells were identi-
cal to those undergoing nuclear fragmentation (fig. 4).
Fig. 2. Apoptotic Saos-2 cells after treatment for 24 h with 300 ÌM
glyoxal (GO) detected by sub-G1 test. ––– = Untreated control. BL
(––––) and FC (W W W W W W) represent treated cells either 300 ÌM glyoxal.
The sub-G1 test shows the influence of FC on the antiapoptotic
behavior of Saos-2 cells after incubation of cells with 300 ÌM GO.
The experiment revealed the lowest apoptotic rate in controls (the
controls grew only on culture plates without glyoxal), followed by
those on FC-coated titanium alloy. The highest apoptotic cell rate we
determined was on BL titanium alloy.
Fig. 3. Apoptotic calvarial cells after 24 h treat-
ment with 200 ÌM glyoxal (GO) cultured on BL
(A, B) and FC (C, D) titanium alloy detected by
reactions with bisbenzimid (A, C) combined with
anti-caspase-3 immunocytochemistry (B, D).
Identical cells are shown in A + B and C + D. The
arrows marked identical cells. The immunocyto-
chemistry demonstrates that only apoptotic cells
(A, C) produced anti-caspase-3 (B, D). Double
immunofluorescence showed that more apoptotic
cells were present on BL (A, B) than on FC (C, D).
Anti-caspase-3 expression was quantitatively de-
creased on FC correlating with a lower number of
apoptotic cells. Scale bar for A–D is 10 Ìm.
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Fig. 4. Apoptotic calvarial cells after 24 h treat-
ment with 200 ÌM glyoxal (GO) cultured on BL
(A, B) and FC (C, D) titanium alloy detected by
reactions with bisbenzimid (A, C) combined with
antifractin immunocytochemistry (B, D). Identi-
cal cells are shown in A + B and C + D. The arrows
marked identical cells. The immunocytochemis-
try demonstrates that only apoptotic cells (A, C)
produced antifractin (B, D). Double immunofluo-
rescence showed that more apoptotic cells were
present on BL (A, B) than on FC (C, D), where
antifractin expression was quantitatively de-
creased on FC correlating with a lower number of
apoptotic cells. Scale bar for A–D is 10 Ìm.
Fig. 5. Apoptotic calvarial cells after 24 h treat-
ment with 200 ÌM glyoxal (GO) cultured on BL
(A, B) and FC (C, D) titanium alloy detected by
reactions with bisbenzimid (A, C) combined with
anti-CML immunocytochemistry (B, D). Identi-
cal cells are shown in A + B and C + D. The arrows
marked identical cells. The immunocytochemis-
try demonstrates that only apoptotic cells (A, C)
produced anti-CML (B, D) expressions. Double
immunofluorescence showed that more apoptotic
cells were present on BL (A, B) than on FC (C, D),
where anti-CML was quantitatively decreased on
FC correlating with a lower number of apoptotic
cells. Scale bar for A–D is 10 Ìm.
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The effect of glyoxal on the accumulation of the AGE
product CML in apoptotic cells was also assessed by dou-
ble immunocytochemistry (fig. 5). These double immuno-
fluorescence assays showed that CML-positive cells were
identical to those undergoing nuclear fragmentation.
Again, the number of these cells (Saos-2) was higher on
uncoated titanium discs than on collagen type I-coated
discs.
Discussion
An implant material attains and maintains contacts
with interfacial tissue through its surface. Since reactions
in vivo are governed by molecular mediators, it is con-
ceivable that these mediators play a role in the process
leading to implant integration or rejection. When a sub-
strate or an implant is inserted into the living tissue, it is
exposed to cells and a large variety of ionic and molecular
species that ultimately affect the course of the events at
the interface between the tissue and the implant.
A very early event in the implantation process is the
adsorption of proteins onto the substrate. Collagen type I
is the predominant matrix protein in the bone tissue and
plays an important role in bone cell-matrix interactions.
The initial adhesion and differentiation of osteoblasts are
improved by coating titanium alloy with collagen type I
[Geissler et al., 2000; Röhlecke et al., 2001; Becker et al.,
2002]. The adhesion of cells to the extracellular matrix
and intercellular contact have been observed to suppress
apoptosis in many cell types. For example, glyoxal treat-
ment in epithelial lung L132 cells induced apoptosis as a
consequence of the loss of cell contacts and simultaneous
downregulation of cell adhesion molecules, such as ß1
integrin, CD44 and ICAM-1 [Röhlecke et al., 2000]. The
collagen framework is also important for the survival of
cells shown in human cartilage [Kim et al., 2001]. Corre-
spondingly, collagenase treatment leads to an increased
apoptosis.
Both p53 and pRb, the latter being a product of the
retinoblastoma gene, are implicated in certain pathways
of apoptosis. Saos-2 cells are defective in the expression of
both p53 and pRb. Nevertheless, our findings indicate
that glyoxal can induce apoptosis of these p53/pRb-nega-
tive cells. In addition, we found that caspase activation is
involved in glyoxal-mediated apoptosis, as caspase-3 ac-
tivity and fractin expression were increased in glyoxal-
treated, bisbenzimid-positive cells.
In diabetic rats and humans, marked abnormalities in
bone metabolism have been described, characterized by a
decreased number of osteoblasts, decreased bone forma-
tion and slow turnover, all of which contribute to osteo-
porosis [Vaeghe et al., 1990; Bouillon et al., 1995]. Treat-
ment with glyoxal promotes the formation of CML resi-
due on proteins, which can mimic diabetes-induced dam-
age [Berg et al., 1998; Rico et al., 1998]. Our present
results prove that glyoxal, indeed, induces the formation
of the AGE product CML and CML accumulation is con-
comitant with a markedly increased apoptosis.
The present findings show (as important findings for
implant modification) that the coating of titanium alloy
with collagen type I exerts a protecting, antiapoptotic
effect on osteoblasts. The mechanisms behind this effect
are still unclear, but one could propose that collagen
exerts a scavenging action on radicals generated by AGEs
[Loske et al., 1998] or that it directly cross-links with
AGEs, as previously suggested [Mentink et al., 2002].
Thus, implants coated with collagen could have beneficial
effects especially in patients with longer implant duration,
advanced age and diabetes.
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